Aemetis (AMTX) Enters Licensing Agreement for Edeniq's Pathway Technology

March 24, 2016 8:48 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Edeniq, Inc., a biorefining and cellulosic technology company, and Aemetis, Inc. (NASDAQ: AMTX) announced they have entered into a License Agreement under which Aemetis will deploy Edeniq's Pathway technology at its 60 million gallon per year ethanol production facility located in Keyes, California.

Edeniq's Pathway Technology integrates Edeniq's Cellunatorâ„¢ equipment with cellulase enzymes to convert corn kernel fiber to cellulosic ethanol. The Pathway Technology utilizes existing fermentation and distillation equipment to produce up to 2.5% cellulosic ethanol and a 7% increase in overall ethanol yield.

"We selected Edeniq's technology because we believe it is the fastest and most cost-efficient route to cellulosic ethanol," said Eric McAfee, Chairman and Chief Executive Officer of Aemetis. "This partnership is part of our commitment to being a leader in the transition toward advanced biofuel production in the United States and globally."

"Aemetis joins a growing list of customers that trust Edeniq to provide best-in-class technology solutions and services," said Brian Thome, President and CEO of Edeniq. "Our team is looking forward to working with the Aemetis team to integrate our technology into their facility."

Edeniq is the leader in developing analytical methods to quantify cellulosic ethanol co-produced with first-generation ethanol during fermentation, which is required to access regulatory value including D3 Renewable Identification Numbers (RINs). Aemetis plans to use Edeniq's methods to submit a registration to the U.S. Environmental Protection Agency for D3 RINs.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Comments

Related Entities

Definitive Agreement